Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Trisalicylic acid is a small molecule compound that serves as a thermal decomposition product of aspirin (acetylsalicylic acid). Structurally, it is a trimer of salicylic acid. It is primarily utilized in research contexts to explore its anti-inflammatory and metabolic effects. Similar to other salicylates, it is investigated for its potential to treat conditions such as obesity, type 2 diabetes, and cardiovascular disease, likely through the modulation of inflammatory pathways and metabolic regulators like NF-κB and AMPK. While it shares properties with salicylic acid and salsalate (disalicylic acid), its specific pharmacological profile as a trimer is a subject of ongoing study.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on trisalicylic acid.